This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Technische Universitaet Muenchen. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Antonius Schumacher
Introduction
Antonius Schumacher is a notable inventor based in Haarlem, Netherlands. He has made significant strides in the field of cancer treatment through his innovative research and development of T cell receptors and peptides.
Latest Patents
Schumacher holds a patent for a method related to T cell receptors and peptides derived by mutations for the treatment of cancer. The patent describes a method for providing a neopeptide-specific T cell, wherein the neopeptide-specific T cell forms a complex having a half-life (T½) of at least 50 seconds with a neopeptide-MHC monomer. This invention also includes a T cell obtainable by the method, as well as a pharmaceutical composition comprising such T cells. He has 1 patent to his name.
Career Highlights
Antonius Schumacher is affiliated with the Technische Universität München, where he contributes to advancing research in immunotherapy and cancer treatment. His work focuses on enhancing the efficacy of T cell therapies, which are crucial in the fight against cancer.
Collaborations
Some of his notable coworkers include Markus Gerhard and Dirk H. Busch, who collaborate with him on various research projects aimed at improving cancer therapies.
Conclusion
Antonius Schumacher's contributions to the field of cancer treatment through his innovative patents and research collaborations highlight his role as a significant figure in medical science. His work continues to pave the way for advancements in immunotherapy.